Skip to main content
. 2020 Spring;19(2):22–33. doi: 10.22037/ijpr.2019.13866.13346

Figure 3.

Figure 3

In-vitro release profiles of propranolol HCl buccoadhesive tablet formulations F1, F2, F4, F5, F7, F11 and F13 (n = 3, mean ± SD).